@article{251, keywords = {decision support, computerized, medication safety, patient safety, quality improvement}, author = {Bruce L. Lambert and William Galanter and King Lup Liu and Suzanne Falck and Gordon Schiff and Christine Rash-Foanio and Kelly Schmidt and Neeha Shrestha and Allen J. Vaida and Michael J. Gaunt}, title = {Automated detection of wrong-drug prescribing errors.}, abstract = {

BACKGROUND: To assess the specificity of an algorithm designed to detect look-alike/sound-alike (LASA) medication prescribing errors in electronic health record (EHR) data.

SETTING: Urban, academic medical centre, comprising a 495-bed hospital and outpatient clinic running on the Cerner EHR. We extracted 8 years of medication orders and diagnostic claims. We licensed a database of medication indications, refined it and merged it with the medication data. We developed an algorithm that triggered for LASA errors based on name similarity, the frequency with which a patient received a medication and whether the medication was justified by a diagnostic claim. We stratified triggers by similarity. Two clinicians reviewed a sample of charts for the presence of a true error, with disagreements resolved by a third reviewer. We computed specificity, positive predictive value (PPV) and yield.

RESULTS: The algorithm analysed 488 481 orders and generated 2404 triggers (0.5% rate). Clinicians reviewed 506 cases and confirmed the presence of 61 errors, for an overall PPV of 12.1% (95% CI 10.7% to 13.5%). It was not possible to measure sensitivity or the false-negative rate. The specificity of the algorithm varied as a function of name similarity and whether the intended and dispensed drugs shared the same route of administration.

CONCLUSION: Automated detection of LASA medication errors is feasible and can reveal errors not currently detected by other means. Real-time error detection is not possible with the current system, the main barrier being the real-time availability of accurate diagnostic information. Further development should replicate this analysis in other health systems and on a larger set of medications and should decrease clinician time spent reviewing false-positive triggers by increasing specificity.

}, year = {2019}, journal = {BMJ Qual Saf}, volume = {28}, pages = {908-915}, month = {12/2019}, issn = {2044-5423}, doi = {10.1136/bmjqs-2019-009420}, language = {eng}, }